Navigation Links
Cardium's Exchange Listing Compliance Plan Accepted by NYSE AMEX
Date:3/8/2010

The notification received from NYSE AMEX LLC had no current effect on the listing of the company's shares on the exchange. Rather, the company was afforded the opportunity to submit a supplement to its compliance plan, pursuant to which the company would seek to establish compliance with the requirements of section 1003(a)(i) and 1003(a)(ii) by June 23, 2010, as called for by the exchange.  The company submitted its supplement to the compliance plan to the exchange on January 26, 2010.

On March 5, 2010, the exchange notified Cardium that, based on its review of information provided by the company, Cardium had made a reasonable demonstration of its ability to regain compliance with the requirements of sections 1003(a)(i) and 1003(a)(ii) of the NYSE AMEX company guide by June 23, 2010.

The company will be subject to periodic review by the exchange staff during the extension period covered by the plan.  Failure to make progress consistent with the plan or to regain compliance with the continued listing standards by the end of the applicable extension periods could result in the company's shares being delisted from the exchange.  If the company's common stock was ultimately delisted from the exchange, it would be expected to trade on the OTC Bulletin Board, a regulated quotation service that provides quotes, sale
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
2. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
3. Genmab Announces Asset Exchange Agreement
4. New SPE Cation Exchange Technology From Varian Simplifies Extraction of Basic Compounds
5. Cell Therapeutics, Inc. Announces Issuance of $23.25 Million in New Convertible Senior Notes in Exchange for $36.08 Million of Existing Convertible Senior Subordinated and Subordinated Notes
6. Max Nutrition, Inc. Completes Share Exchange with American Spring Pharmaceutical, Inc.
7. Life Science Executive Exchange 2008 To Sponsor Industry Awards
8. American Stock Exchange Lists the Common Stock of Rexahn Pharmaceuticals, Inc.
9. China Sun Group High-Tech Co. Completes Share Exchange to Create 100% Ownership in DLX Subsidiary
10. PLC Systems Receives Delisting Notice From American Stock Exchange
11. Monterey Spine and Joint Deploys WebLOQ ePrivacy Solution for HIPAA Compliant Health Information Exchange
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 The largest international professional organization of ... therapeutic derivatives thereof has endorsed an educational program ... the challenges of adulterated herb and botanical products. ... The Society for Medicinal Plant and Natural ...
(Date:1/14/2014)... Boston, MA (PRWEB) January 14, 2014 iLab ... Michelle Detwiler as the new Director of Product Strategy. In ... as well as iLab sub-teams to guide in the development ... that iLab provides the maximum possible benefit to the scientific ...
(Date:1/14/2014)... , Jan. 14, 2014  RXi Pharmaceuticals Corporation (OTCQX: ... and commercializing innovative therapies addressing major unmet medical ... received the Notice of Allowance from the United ... self-delivering RNAi compounds (sd-rxRNA®), for the treatment of ...
(Date:1/14/2014)...   Kinaxis ®, provider of RapidResponse ®, a cloud-based ... planning ( S&OP ) service, is proud to be a ... be held at the Hilton San Diego Bayfront, January 30 ... Elisabeth Kaszas , Director of Supply Chain at Amgen, as ...
Breaking Biology Technology:World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... examination gloves made from U.S.-sourced guayule rubber ... latex allergy, MARICOPA, Ariz., April 24 Yulex ... safe for medical devices, received,510(k) clearance from the U.S. ... device made from guayule, a desert crop native to ...
... England, April 24 The Board of,Directors of ... the global specialty,biopharmaceutical company, announces today that Michael ... Director with immediate effect., Dr Rosenblatt is ... Massachusetts. He was previously Professor of Medicine at ...
... /PRNewswire/ - Aegera Therapeutics Inc. is very,pleased to ... executives to its Board of Directors: Mr. Jeremy ... Limited, and Mr. Gary,Littlejohn, Managing Director of Desjardins ... and networks will be,critical for Aegera as we ...
Cached Biology Technology:FDA Clears First Medical Product Made From Yulex(R) Natural Rubber 2Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 2Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 3Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 4Aegera Therapeutics welcomes two experienced executives to its board of directors 2
(Date:4/17/2014)... under clinical trials to treat tuberculosis could be the ... against various bacteria, fungal infections and parasites, yet evade ... chemists and collaborators. , Led by U. of I. ... ways the drug SQ109 attacks the tuberculosis bacterium, how ... from yeast to malaria and how targeting multiple ...
(Date:4/17/2014)... study suggests that fish consumption advisories for expecting ... long-lived contaminants like persistent organic pollutants (POPs). ... researchers including University of Toronto Scarborough PhD student ... how different levels of environmental contamination, a mother,s ... in the body influenced exposure in her children. ...
(Date:4/17/2014)... KAN. A Kansas State University engineer has ... and remotely detects improvised explosive devices. The same ... William Dunn, the Steven M. and Kay L. ... mechanical and nuclear engineering, and his research team ... hidden underground or in car trunks. The distance ...
Breaking Biology News(10 mins):Multitarget TB drug could treat other diseases, evade resistance 2Fish consumption advisories fail to cover all types of contaminants 2Patented research remotely detects nitrogen-rich explosives 2
... 1, 2011 JERUSALEM, Israel EUREKA the ... supported by 40 member states and mobilizing more than ... today announced the launch of "E!nnoVest", its new ... This web-based instrument allows investors to identify highly-qualified and ...
... Industrial Revolution, over half of all the CO2 produced by ... pH drop faster than any time in the last 650,000 ... that this causes fish to lose their sense of smell, ... shows that fish hearing is also compromised. Working ...
... beetles march across the forests of western North America, ... a single outbreak. A rise in overall temperatures over ... mountain pine beetles, resulting in an epidemic and possibly ... blight to occur in North America. Dr. Francois ...
Cached Biology News:Ocean acidification leaves clownfish deaf to predators 2Storing seeds for a rainy day -- or in this case, a fire 2
... inserts fit into the Universal ... you to greatly increase your ... format plates at an angle, ... the shaker at once for ...
BD FastImmune EDTA Solution. Applications: Flow Cytometry Storage Temperature: Refrigerate(2 to 8C)...
Spaced cover glasses to promote effective hybridization...
prototype Nco I...
Biology Products: